These results further validated that HNF4α could perform a tumor-suppressing function in prostate cancer cells as its overexpression could repress both in vitro and in vivo malignant growth of prostate cancer cells regardless of their AR and p53 expression status. Here, TP53 is linked to prostate cancer.